NU SKIN ENTERPRISES, INC. - FORM 8-K/A - EX-99.1 - CORRECTION TO PRESS RELEASE DATED AUGUST 1, 2013

Attached files

file	filename
8-K/A - CORRECTION TO EARNINGS RELEASE DATED AUGUST 1, 2013 REPORTING 2Q AND FIRST SIX MONTHS OF 2013 FINANCIAL RESULTS - NU SKIN ENTERPRISES, INC.	q2earncorrect8k.htm

FOR IMMEDIATE RELEASE

CONTACTS:

Investors — Scott Pond (801) 345-2657, spond@nuskin.com
Media — Kara Schneck (801) 345-2116, kschneck@nuskin.com

CORRECTION -- Nu Skin Enterprises, Inc.

In the news release, Nu Skin Enterprises Reports Record Second-Quarter Results, issued 01-Aug-2013 by Nu Skin Enterprises, Inc. over PR Newswire, the earnings release included an inadvertent typographical error. While the annual guidance of $2.91 to $2.95 billion in revenue and the annual earnings per share of $5.05 to $5.15, as well as the revenue guidance for the third quarter of $790 to $810 million were correctly stated, the last sentence in the third paragraph of the Outlook section contained an error. The earnings per share guidance for the third quarter should have been "$1.35 to $1.40." The complete, corrected release follows:

NU SKIN ENTERPRISES REPORTS RECORD SECOND-QUARTER RESULTS

Company raises annual sales forecast $90 million

Nu Skin Enterprises, Inc. (NYSE: NUS) today announced record second-quarter results with revenue of $682.9 million, a 15 percent increase over the prior-year period. Revenue for the quarter was negatively impacted 3 percent by foreign currency fluctuations. Quarterly earnings per share increased 30 percent to $1.22 from $0.94 in the prior year.

"We are extremely pleased with second-quarter results that reflect the strong momentum of the business," said Truman Hunt, president and chief executive officer. "We are particularly pleased with these results given the record regional ageLOC product launches in the prior-year period. Additionally, we generated continued growth of both our consumer and sales leader base, reflected in 32 percent growth in actives and 23 percent growth in sales leaders. Overall, we saw healthy trends throughout the global business, particularly in the Greater China, North Asia and Americas regions."

-more-

Nu Skin Enterprises, Inc.

Aug. 1, 2013
Page 2

"Sales force enthusiasm for the introduction of our ageLOC TR90 weight management system bodes well for a strong second half of the year. We plan to begin the limited-time offer of ageLOC TR90 in September and believe this new product provides an ideal vehicle for us to increase our presence in the growing weight management category."

Regional Results

Greater China. In Greater China, second-quarter revenue increased 35 percent to $269.1 million, compared to $199.7 million in the prior year, which included approximately $100 million in product launch revenue. The region's results were negatively impacted 3 percent by foreign currency fluctuations. The sales leader count in the region improved 51 percent, while the number of actives increased 121 percent compared to the prior year.

North Asia. Second-quarter revenue in North Asia was $196.8 million, compared to $177.7 million for the same period of 2012. The region's results were negatively impacted 12 percent by foreign currency fluctuations. Japan local-currency revenue improved 5 percent and South Korea generated local-currency revenue growth of 54 percent. The number of sales leaders in the region was up 21 percent while the number of actives improved 15 percent.

South Asia/Pacific. Revenue in South Asia/Pacific was $85.9 million, a 13 percent decline compared to the prior year. Revenue in the prior year included approximately $40 million in product launch sales. Results were not notably impacted by foreign currency fluctuations. The region's second-quarter sales leaders decreased 20 percent while actives increased 16 percent compared to the same period in 2012.

Americas. Revenue in the Americas improved 17 percent to $84.3 million, compared to $71.8 million in the prior-year period. The region's results were negatively impacted 5 percent by foreign currency fluctuations. The number of sales leaders in the region improved 16 percent while the number of actives increased 3 percent compared to the prior year.

-more-

Nu Skin Enterprises, Inc.

Aug. 1, 2013
Page 3

EMEA. Revenue in the EMEA region was $46.8 million, a 2 percent improvement over the prior-year period. The region's results were positively impacted 1 percent by foreign currency fluctuations. Sales leaders decreased 3 percent, while actives increased 4 percent compared to the prior year.

Operational Performance

The company's operating margin was 16.8 percent for the quarter, compared to 16.5 percent, while gross margin was 83.7 percent, compared to 83.9 percent in the prior year. Selling expenses, as a percent of revenue, were 45.2 percent in the second quarter. General and administrative expenses, as a percent of revenue, improved to 21.7 percent from 22.3 percent in the prior-year period. Other income (expense) reflected an expense of $1.1 million compared to a $3.4 million expense in the prior year.

The company's income tax rate for the quarter was 34.4 percent compared to 36.1 percent in the prior-year period. The company's cash and short-term investment position at the end of the quarter was $411.4 million. Dividend payments were $17.6 million.

Outlook

"As we look to the back half of the year, we are ramping up for what we expect to be our largest-ever product launch," said Hunt. "Given the growth momentum of the business, we are again increasing the sales forecast for the remainder of the year. We expect the upcoming launch of ageLOC TR90 and the strength of the business in several key markets will lead to another record year as annual revenue will approach the $3 billion mark," Hunt concluded.

"Given the significant growth in our actives, we are raising our annual sales guidance by $90 million to $2.91 to $2.95 billion," said Ritch Wood, chief financial officer. We now expect earnings per share to be $5.05 to $5.15 and continue to project a negative 5 percent foreign currency impact to annual revenue."

-more-

Nu Skin Enterprises, Inc.

Aug. 1, 2013
Page 4

"In the third quarter, we will introduce ageLOC TR90 for a limited time in the Greater China region and much of South Asia in advance of our global convention," continued Wood. "With these ageLOC TR90 sales, we anticipate third-quarter revenue to be between $790 and $810 million, with a negative currency impact to revenue of 6 to 7 percent. We anticipate earnings per share to be $1.35 to $1.40 for the quarter," concluded Wood.

The company's management will host a webcast with the investment community on Aug. 1, 2013, at 11 a.m. EDT. Those wishing to access the webcast, as well as the financial information presented during the call, can visit the Investor Relations page on Nu Skin Enterprises' website, http://ir.nuskin.com. An archive of the webcast will be available at this same URL through Aug. 16, 2013.

About Nu Skin Enterprises, Inc.

Nu Skin Enterprises, Inc. demonstrates its tradition of innovation through its comprehensive anti-aging product portfolio, independent business opportunity and corporate social responsibility initiatives. The company's scientific leadership in both skin care and nutrition has established Nu Skin as a premier anti-aging company. The company's anti-aging products feature the new ageLOC^® suite of products including the ageLOC^® R² nutritional supplement, ageLOC^® Galvanic Spa System and ageLOC^® Galvanic Body Spa™, as well as the ageLOC^® Transformation daily skin care system. A global direct selling company, Nu Skin operates in 53 markets worldwide and is traded on the New York Stock Exchange under the symbol "NUS." More information is available at http://www.nuskin.com.

Please Note: This press release, particularly the "Outlook" section, contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended that represent the company's current expectations and beliefs. All statements other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws and include, but are not limited to, statements of management's expectations regarding the company's performance, initiatives, strategies, new product introductions and growth in the company's markets, including mainland China; statements of projections regarding revenue, earnings per share, foreign currency impact and other financial items; statements of belief; and statements of assumptions underlying any of the foregoing. In some cases, you can identify these statements by forward-looking words such as "believe," "expect," "project," "anticipate," "estimate," "intend," "plan," "targets," "likely," "will," "would," "could," "may," "might," the negative of these words and other similar words.

-more-

Nu Skin Enterprises, Inc.

Aug. 1, 2013
Page 5

The forward-looking statements and related assumptions involve risks and uncertainties that could cause actual results and outcomes to differ materially from any forward-looking statements or views expressed herein. These risks and uncertainties include, but are not limited to, the following:

·	any failure of current or planned initiatives or products to generate interest among distributors and customers and generate sponsoring and selling activities on a sustained basis;

·	risks related to accurately predicting, delivering or maintaining sufficient quantities of products to support our planned initiatives or launch strategies, including possible ingredient supply limitations;

·	challenging economic conditions globally;

·	risk of foreign currency fluctuations and the currency translation impact on the company's business associated with these fluctuations;

·	risks associated with general inquiries and complaints to consumer protection agencies in Japan regarding the activities of some distributors;

·	risks associated with our ability to manage rapid growth, particularly in our greater China region;

regulatory risks associated with the company's products, which could require the company to modify its claims or inhibit the company's ability to import or continue selling a product in a market if it is determined to be a medical device or if it is unable to register the product in a timely manner under applicable regulatory requirements;

·	continued regulatory scrutiny and investigations in Mainland China, which have from time to time in the past, and could in the future, negatively impact the company's business, including the interruption of sales activities in stores, loss of licenses, and the imposition of fines;

·	adverse publicity related to the company's business, products, industry or any legal actions or complaints by distributors or others;

·	any prospective or retrospective increases in duties on the company's products imported into the company's markets outside of the United States and any adverse results of tax audits or unfavorable changes to tax laws in the company's various markets; and

·	continued competitive pressures in the company's markets.

The company's financial performance and the forward-looking statements contained herein are further qualified by a detailed discussion of associated risks set forth in the documents filed by the company with the Securities and Exchange Commission. The forward-looking statements set forth the company's beliefs as of the date that such information was first provided and the company assumes no duty to update the forward-looking statements contained in this release to reflect any change except as required by law.

-more-

Nu Skin Enterprises, Inc.

Aug. 1, 2013
Page 6

NU SKIN ENTERPRISES, INC.
Consolidated Statements of Income (Unaudited)
For the Second Quarters Ended June 30, 2013 and 2012
(in thousands, except per share amounts)

	2013			2012
Revenue:
Greater China	$	269,146		$	199,728
North Asia		196,757			177,695
South Asia/Pacific		85,916			98,344
Americas		84,289			71,766
EMEA		46,819			45,702

Total revenue		682,927			593,235

Cost of sales		111,273			95,584

Gross profit		571,654			497,651

Operating expenses:
Selling expenses		308,769			267,363
General and administrative expenses		148,302			132,376
Total operating expenses		457,071			399,739

Operating income		114,583			97,912

Other income (expense), net		(1,187	)		(3,369	)
Income before provision for income taxes		113,396			94,543
Provision for income taxes		38,961			34,136

Net income	$	74,435		$	60,407

Net income per share:
Basic	$	1.27		$	0.98
Diluted	$	1.22		$	0.94

Weighted average common shares outstanding:
Basic		58,620			61,706
Diluted		61,121			64,230

-more-

Nu Skin Enterprises, Inc.

Aug. 1, 2013
Page 7

NU SKIN ENTERPRISES, INC.
Consolidated Statements of Income (Unaudited)
For the Six Month Periods Ended June 30, 2013 and 2012
(in thousands, except per share amounts)

	2013			2012
Revenue:
Greater China	$	444,852		$	292,339
North Asia		384,950			359,895
South Asia/Pacific		153,158			175,665
Americas		160,830			138,106
EMEA		89,231			89,232

Total revenue		1,233,021			1,055,237

Cost of sales		201,318			171,340

Gross profit		1,031,703			883,897

Operating expenses:
Selling expenses		550,652			469,898
General and administrative expenses		283,809			244,424
Total operating expenses		834,461			714,322

Operating income		197,242			169,575

Other income (expense), net		(1,075	)		266
Income before provision for income taxes		196,167			169,841
Provision for income taxes		67,450			61,605

Net income	$	128,717		$	108,236

Net income per share:
Basic	$	2.20		$	1.75
Diluted	$	2.11		$	1.67

Weighted average common shares outstanding:
Basic		58,487			62,016
Diluted		60,882			64,773

-more-

Nu Skin Enterprises, Inc.

Aug. 1, 2013
Page 8

NU SKIN ENTERPRISES, INC.
Consolidated Balance Sheets (Unaudited)
(in thousands)

	June 30, 2013			December 31, 2012
ASSETS
Current assets:
Cash and cash equivalents	$	402,678		$	320,025
Current investments		8,754			13,378
Accounts receivable		59,043			36,850
Inventories, net		178,183			135,874
Prepaid expenses and other		117,138			93,276
		765,796			599,403

Property and equipment, net		304,619			229,787
Goodwill		112,446			112,446
Other intangible assets, net		87,644			92,518
Other assets		122,202			118,753
Total assets	$	1,392,707		$	1,152,907

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable	$	48,954		$	47,882
Accrued expenses		355,215			233,202
Current portion of long-term debt		69,461			39,019
		473,630			320,103

Long-term debt		128,664			154,963
Other liabilities		98,326			87,229
Total liabilities		700,620			562,295

Stockholders' equity:
Class A common stock		91			91
Additional paid-in capital		332,588			317,293
Treasury stock, at cost		(718,800	)		(714,853	)
Accumulated other comprehensive loss		(55,272	)		(51,822	)
Retained earnings		1,133,480			1,039,903
		692,087			590,612
Total liabilities and stockholders' equity	$	1,392,707		$	1,152,907

-more-

Nu Skin Enterprises, Inc.

Aug. 1, 2013
Page 9

NU SKIN ENTERPRISES, INC. Actives/Sales Leaders Statistics

	As of June 30, 2013				As of June 30, 2012				% Increase (Decrease)
	Actives		Sales Leaders		Actives		Sales Leaders		Actives		Sales Leaders

Greater China		376,000		30,455		170,000		20,182		121.2%		50.9%
North Asia		389,000		17,372		337,000		14,370		15.4%		20.9%
South Asia/Pacific		114,000		7,120		99,000		8,856		15.2%		(19.6%)
Americas		176,000		6,954		170,000		5,994		3.5%		16.0%
EMEA		124,000		4,484		119,000		4,626		4.2%		(3.1%)

Total		1,179,000		66,385		895,000		54,028		31.7%		22.9%

"Actives" are persons who purchased products directly from the company during the previous three months.

"Sales Leaders" are persons who have completed and who maintain specified sales requirements. Sales Leaders include our independent distributors who have completed and who maintain specified sales requirements, and our sales employees and contractual sales promoters in China, who have completed certain qualification requirements.

###

Attached files

Stock widget

Investing forum

NU SKIN ENTERPRISES, INC. Reports